Research Article| Volume 13, ISSUE 2, P217-218, February 1984

Thromboxane formation during blood clotting is decreased by verapamil

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Henry P.D.
        Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.
        Am J Cardiol. 1980; 46: 1047-1058
        • Addonizio V.P.
        • Fisher C.A.
        • Edmunds L.H.
        Effects of verapamil and nifedipine on platelet activation.
        Circulation. 1980; 62: 326
        • Rittenhouse-Simmons S.
        • Russell F.A.
        • Deykin D.
        Mobilization of arachidonic acid in human platelets. Kinetics and Ca 2+ dependency.
        Biochim Biophys Acts. 1977; 488: 370-380
        • Hamberg M.
        • Svensson J.
        • Samuelsson B.
        Thromboxanes: A near group of biologically active compounds derived from prostaglandin endoperoxides.
        in: Proc Natl Aced Sci USA. 72. 1975: 2994-2998
        • Patrono C.
        • Ciabattoni G.
        • Pugliese F.
        • Pinca E.
        • Castrucci G.
        • De Salvo A.
        • Satta M.A.
        • Parachini M.
        Radio mmunoassay of serum thrombrnone B : A simple method of assessing pharmacologic effects on platelet function.
        in: Samuelsson B. Ramwell P.W. Paoletti R. Advances in prostaglandin and thromboxane research. 6. Raven Press, Newr York1980: 187-191